1. Диагностика и лечение боли. Под ред.  Дж.Х.Ван Роенн, Дж.А.Пэйс, М.И.Преодер. М.: БИНОМ, 2012.
2. Кукушкин М.Л., Хитров Н.К. Общая патология боли. М.: Медицина, 2004.
3. Пшенникова М.Г., Смирнова В.С., Графова В.Н. и др. Устойчивость к развитию невропатического болевого синдрома у крыс линии август и популяции вистар, обладающих разной врожденной устойчивостью к стрессовому воздействию. Рос. журн. боли. 2008; 2: 13–6.
4. Эpдес Ш.Ф., Дубинина Т.В., Галушко Е.А. Боли в нижней части спины в общеклинической пpактике. Терапевт. арх. 2008; 5: 59–61.
5. Яхно Н.Н., Кукушкин М.Л., Данилов А.Б. и др. Результаты Российского эпидемиологического исследования распространенности невропатической боли, ее причин и характеристик в популяции амбулаторных больных, обратившихся к врачу-неврологу. Рос. журн. боли. 2008; 3: 24–32.
6. Боль (практич. руководство для врачей). Под ред. Н.Н.Яхно, М.Л.Кукушкина. М.: РАМН, 2011.
7. Яхно Н.Н., Кукушкин М.Л. Хроническая боль: медико-биологические и социально-экономиченские аспекты. Вестн. РАМН. 2012; 9: 54–8.
8. Яхно Н.Н., Кукушкин М.Л., Чурюканов М.В., Сыровегин А.В. Результаты открытого мультицентрового исследования «МЕРИДИАН» по оценке распространенности болевых синдромов в амбулаторной практике и терапевтических предпочтений врачей. Рос. журн. боли. 2012; 3–4: 10–4.
9. Arnold LM, Lu Y, Crofford LJ et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004; 50 (9): 2974–84.
10. Arnold LM, Rosen A, Pritchett YL et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005; 119 (1–3): 5–15.
11. Arnold LM, Clauw DJ, Wohlreich MM et al. Efficacy of duloxetine in patients with fibromyalgia: pooled analysis of 4 placebo-controlled clinical trials. Prim Care Companion J Clin Psychiatry 2009; 11 (5): 237–44.
12. Attal N, Cruccu G, Haanpaa M et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006; 13: 1153–69.
13. Breivik H, Collett B, Ventafridda V et al. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain 2006; 10: 287–333.
14. Buskila D. Genetics of chronic pain states. Best Pract Res Clin Rheumatol 2007; 21: 535–47.
15. Buskila D, Sarzi-Puttini P, Ablin JN. The genetics of fibromyalgia syndrome. Pharmacogenomics 2007; 8: 67–74.
16. Chappell AS, Bradley LA, Wiltse C et al. A six-month double blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia. Int J Gen Med 2008; 1: 91–102.
17. Chappell AS, Desaiah D, Liu-Seifert H et al. A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee. Pain Pract 2010; 11 (1): 33–41.
18. Chappell AS, Ossanna MJ, Liu-Seifert H et al. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain 2009; 146 (3): 253–60.
19. Merskey H, Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms/prepared by International Association for the Study of Pain, Task Force on Taxonomy. 2nd ed. Seattle: IASP Press 1994.
20. Diatchenko L, Nackley AG, Slade GD et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2007; 129: 365–70.
21. Diatchenko L, Slade GD, Nackley AG et al. Maixner Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Human Molecular Genetics 2005; 14 (1): 135–43.
22. Edwards RR. Genetic predictors of acute and chronic pain. Curr Rheumatol Rep 2006; 8: 411–7.
23. Goldstein DJ, Lu Y, Detke MJ et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005; 116 (1–2): 109–8.
24. Jetzer AK, Morel A, Magnin M, Jeanmonod D. Cross-modal plasticity in the human thalamus: evidence from intraoperative macrostimulations. Neurosci 2009; 164: 1867–75.
25. Lacroix-Fralish ML, Mogil JS. Progress in genetic studies of pain and analgesia. Annu Rev Pharmacol Toxicol 2009; 49: 97–121.
26. Mease PJ, Walker DJ, Alaka K. Evaluation of duloxetine for chronic pain conditions. Pain Manage 2011; 1 (2): 159–70.
27. Raskin J, Pritchett YL, Wang F et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005; 6 (5): 346–56.
28. Russell IJ, Mease PJ, Smith TR et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 2008; 136 (3): 432–44.
29. Seifert F, Maihöfner C. Functional and structural imaging of pain-induced neuroplasticity. Curr Opin Anaesthesiol 2011; 24: 515–23.
30. Skljarevski V, Desaiah D, Liu-Seifert H et al. Efficacy and safety of duloxetine in patients with chronic low back pain. Spine 2010; 35 (13): E578–E585.
31. Skljarevski V, Ossanna M, Liu-Seifert H et al. A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. Eur J Neurol 2009; 16 (9): 1041–8.
32. Skljarevski V, Zhang Q, Desaiah D et al. Duloxetine versus placebo in ­patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial. J Pain 2010; 11 (12): 1282–90.
33. Torrance N, Elliot AM, Lee AJ, Smith BH. Severe chronic pain is associated with increased 10 year mortality. A cohort record linkage study. Eur J Pain 2010; 14: 380–6.
34. Treede RD, Jensen TS, Campbell GN et al. Neuropathic pain: redefinition and a grading system for clinical and research diagnostic purposes. Neurology 2008; 70: 3680–5.
35. Tunks ER, Weir R, Crook J. Epidemiologic Perspective on Chronic Pain Treatment. Can J Psychiatry 2008; 53 (4): 235–42.
36. McMahon SB, Koltzenburg M. Wall and Melzack’s Textbook of Pain. 5th Ed. Elsevier Churchill Livingstone 2005.
37. Wernicke JF, Pritchett YL, D’Souza DN et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006; 67 (8): 1411–20.

М.Л.Кукушкин

Лаборатория фундаментальных и прикладных проблем боли НИИ общей патологии и патофизиологии РАМН, Москва